Opinion · 29 Nov 2023
EditorialPublished 2015
BCL-2 inhibitors for Chronic Lymphocytic Leukemia
Subjects
HaematologySimilar by topic
Mini review · 26 Sep 2023
Treatment Refractoriness to Pathway Inhibitors in Chronic Lymphocytic Leukemia
Conference abstract · 13 Jul 2015
Development and validation of clinical next generation sequencing assay for sensitive detection of mutations of BTK and PLC gamma genes in chronic lymphocytic leukemia patients treated with BTK inhibitor Ibrutinib
Editorial · 2013
Inhibitors of B-Cell Receptor Signaling for the Treatment of Chronic Lymphocytic Leukemia
Conference abstract · 1 Oct 2012
Bcl-2 Antagonists: Targeted therapeutics in chronic lymphocytic leukemia
More from this journal
The newest in Journal of Leukemia.
Opinion · 30 Dec 2025
Acute Lymphoblastic Leukemia Management from Conventional Chemotherapy to Precision-Based Treatment Approaches
Opinion · 30 Dec 2025
Stem Cell Transplantation in the Era of Precision Medicine Molecular Insights Therapeutic Strategies and Clinical Applications
Perspective · 30 Dec 2025
The Evolving Landscape of Leukemia Advances in Molecular Biology Immunotherapy and Clinical Outcomes
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Leukemia
- SubjectHaematology
- BylineArticles whose byline prints “Tadeusz Robak”

